pipette
ESEspañol

Facial Emotion Processing and GABAergic Modulation in Individuals at Clinical High-Risk for Psychosis

N. C. Julius, P. B. Lukow, A. Kiemes, N. R. Livingston, M.-M. Avram, S. R. Knight, P. C. Hawkins, O. O'Daly, L. Jelen, T. J. Reilly, A. Dima, M. A. Nettis, C. Casetta, N. Vorontsova, J. Davies, M. B. Wall, T. J. Spencer, A. de Micheli, P. Fusar-Poli, A. A. Grace, K. Ruparel, R. C. Gur, F. Zelaya, S. C. Williams, P. McGuire, F. Turkheimer, M. A. Mehta, E. Chesney, G. Modinos

Preprint

In the authors' words

Deficits in social cognition, including facial emotion recognition (FER), are present in individuals at clinical high-risk for psychosis (CHR-P). Altered GABAergic and glutamatergic signalling within corticolimbic circuitry has been proposed to underlie FER deficits in psychosis. We investigated FER performance and brain activation in CHR-P individuals, and whether pharmacological enhancement of GABAergic signalling with diazepam modulates these processes. In Study 1, 24 antipsychotic-naive CHR-P individuals and 24 healthy controls underwent fMRI while performing the Penn Emotion Recognition Task. In Study 2, 24 antipsychotic-naive CHR-P individuals participated in a randomised, double-blind, placebo-controlled, crossover study of 5mg diazepam versus placebo. Threat-related FER performance and neural activation were compared between groups and drug conditions. In Study 1, CHR-P individuals showed longer reaction times across emotions (n=22 vs n=23, p=0.01) and greater amygdala (pFWE=0.01) and hippocampal (pFWE=0.04) activation for neutral>fixation. Lower amygdala activation for threat>neutral (pFWE=0.03) and non-threat>neutral (pFWE=0.01), and lower hippocampal activation for non-threat>neutral (pFWE=0.04) may reflect this elevated response to neutral faces. Follow-up analyses showed lower insula (pFWE=0.01) and medial prefrontal cortex activation (pFWE=0.02) for threat>fixation. In Study 2, no significant drug effect on sensitivity was observed in the full sample (n=23), although secondary reduced-sample analyses, excluding one participant identified as influential, suggested improved overall sensitivity under diazepam (n=22; p=0.0499). After adjusting for global cerebral blood flow, diazepam reduced midcingulate cortex activation during neutral>fixation (pFWE=0.04). These findings highlight altered neural processing of neutral expressions in individuals at CHR-P, and suggest that aspects of emotion processing may be sensitive to GABAergic modulation.

Main resultLimitation the authors admit

Appeared: Tuesday, November 17. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.12.26367443